#1: Voters and lawmakers in three more states enacted laws in 2022 legalizing adult-use marijuana possession and regulating retail cannabis markets.
Region: United States
Investigators summarized, “Due to its effectiveness and convenience, medical marijuana therapy may be helpful for patients suffering from migraines.”
Patients with anxiety disorders are eligible to access medical cannabis products on January 1, 2023.
Investigators concluded, “Well-being, anxiety, sleep disturbance, and pain significantly improved among those assigned to take a CBD product relative to controls.”
Under the new law, the Attorney General is provided with a 60-day timeline to either approve or deny applications from scientists wishing to conduct human trials with cannabis.
Study: Medical Cannabis Legalization Associated with Lower Rates of Opioid Use Among Cancer Patients
Medical marijuana legalization was “associated with a five percent to 20 percent relative reduction in the rate of opioid dispensing to adults younger than 65 years receiving cancer treatment.”
“[M]easures related to cannabis dispensaries … were generally consistently associated with lower drug overdose mortality outcomes across multiple studies,” investigators concluded.
The study is the largest double-blind, randomized, placebo-controlled clinical trial ever conducted involving FSX patients.